Ampion Uses, Dosage, Side Effects and more
Ampion is under investigation in clinical trial NCT03349645 (An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee).
| Trade Name | Ampion |
| Generic | Aspartyl-alanyl-diketopiperazine |
| Type | |
| Formula | C7H10N2O4 |
| Weight | Average: 186.167 Monoisotopic: 186.06405681 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
